Ivy Rx vs LifeMD
Neither Ivy Rx nor LifeMD has an FDA warning letter on record. No price lines up like for like: Ivy Rx and LifeMD publish prices for different products.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Ivy Rx / LifeMD
Ivy Rx
7.3/10
LifeMD
6.0/10
Neither Ivy Rx nor LifeMD pays us. Links to them earn nothing. Scores: Ivy Rx 7.3, LifeMD 6.0. How we are paid
What the record shows
- 01
Neither Ivy Rx nor LifeMD has an FDA warning letter on record.
- 02
Ivy Rx names no compounding pharmacy in our record. LifeMD sells brand-name medication only.
- 03
No price lines up like for like: Ivy Rx and LifeMD publish prices for different products.
- 04
Only Ivy Rx lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only LifeMD lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Ivy Rx
LifeMD
$197/mo
$2,364 a year
$297/mo
$3,564 a year
$348/mo
$4,176 a year
$448/mo
$5,376 a year
$298/mo
$3,576 a year
Read off each seller’s own pages. Ivy Rx: July 10, 2026. LifeMD: October 31, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Ivy Rx
7.3/10- Sells compounded semaglutide injection and compounded tirzepatide injection, which LifeMD does not price
- Names no compounding pharmacy
The case for LifeMD
6.0/10- Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Ivy Rx does not price
- Price leaves out medication
Scores
Ivy Rx 7.3 · LifeMD 6.0 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Ivy Rx vs LifeMD: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- TrimRx6.4
From $299/mo
Visit site - Direct Meds7.1
From $249/mo
Visit site - SnagRx9.2
From $99/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks